Suzhou Rainmed Medical Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Suzhou Rainmed Medical Technology Co., Ltd. - overview
Established
2016
Location
Suzhou, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Established in 2016 and based in Suzhou, China, Suzhou Rainmed Medical Technology Co. , Ltd. operates as a cardiovascular disease medical device manufacturer that provides cardiovascular disease medical device. Mr.
Yonghui Lv, the CEO of the company, once served as deputy general manager of Lepu Medical Technology (Beijing) Co. , Ltd. In 2015, the company built an animal laboratory. In 2022, it was listed on the Hong Kong Stock Exchange.
Its stock code is 2297. The company provides cardiovascular disease medical device. The company obtained China’s NMPA marketing approval and EU CE certification. The business of the company includes the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems.
The company's product includes FlashAngio caFFR System and FlashAngio caIMR System. The company will promote vascular intervention surgery machine in the next 3 years.
Current Investors
Ping An Trust, Serica Partners Asia, Lighthouse Canton
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices, Surgical Devices
Website
www.rainmed.com
Verticals
Robotics
Company Stage
Mature
Total Amount Raised
Subscriber access only
Suzhou Rainmed Medical Technology Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.